SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-070196
Filing Date
2019-03-11
Accepted
2019-03-11 09:21:33
Documents
6
Period of Report
2019-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d692608d8k.htm 8-K 22631
2 EX-1.1 d692608dex11.htm EX-1.1 355917
3 EX-4.1 d692608dex41.htm EX-4.1 78300
4 EX-4.2 d692608dex42.htm EX-4.2 78324
5 EX-5.1 d692608dex51.htm EX-5.1 12320
6 GRAPHIC g692608g27o88.jpg GRAPHIC 10017
  Complete submission text file 0001193125-19-070196.txt   557116
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 19671125
SIC: 2834 Pharmaceutical Preparations